{"pmid":32497811,"title":"Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?","text":["Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?","The coronavirus 2 (SARS-CoV-2) pandemic is viciously spreading through the continents with rapidly increasing mortality rates. Current management of COVID-19 is based on that respiratory failure is the leading cause of mortality. However, mounting evidence link accelerated pathogenesis in gravely ill COVID-19 patients to a hyper-inflammatory state involving a cytokine storm. Several components of the heightened inflammatory state were addressed as therapeutic targets. Another key component of the heightened inflammatory state is hyper-ferritinemia which reportedly identifies patients with increased mortality risk. In spite of its strong association with mortality, it is not yet clear if hyper-ferritinemia in COVID-19 patients is merely a systemic marker of disease progression, or a key modulator in disease pathogenesis. Here we address implications of a possible role for hyper-ferritinemia, and altered iron homeostasis in COVID-19 pathogenesis, and potential therapeutic targets in this regard.","Int J Infect Dis","Edeas, Marvin","Saleh, Jumana","Peyssonnaux, Carole","32497811"],"abstract":["The coronavirus 2 (SARS-CoV-2) pandemic is viciously spreading through the continents with rapidly increasing mortality rates. Current management of COVID-19 is based on that respiratory failure is the leading cause of mortality. However, mounting evidence link accelerated pathogenesis in gravely ill COVID-19 patients to a hyper-inflammatory state involving a cytokine storm. Several components of the heightened inflammatory state were addressed as therapeutic targets. Another key component of the heightened inflammatory state is hyper-ferritinemia which reportedly identifies patients with increased mortality risk. In spite of its strong association with mortality, it is not yet clear if hyper-ferritinemia in COVID-19 patients is merely a systemic marker of disease progression, or a key modulator in disease pathogenesis. Here we address implications of a possible role for hyper-ferritinemia, and altered iron homeostasis in COVID-19 pathogenesis, and potential therapeutic targets in this regard."],"journal":"Int J Infect Dis","authors":["Edeas, Marvin","Saleh, Jumana","Peyssonnaux, Carole"],"date":"2020-06-05T11:00:00Z","year":2020,"_id":"32497811","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.ijid.2020.05.110","keywords":["ferroptosis","hyper-ferritinemia","hypercoagulability","iron homeostasis","mitochondria","oxidative stress"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668712823965876225,"score":9.490897,"similar":[{"pmid":32459524,"title":"Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes.","text":["Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes.","Recent reports have shown a strong association between obesity and the severity of COVID-19 infection, even in the absence of other co-morbidities. After infecting the host cells, SARS-CoV-2 may cause a hyper-inflammatory reaction through the excessive release of cytokines, a condition known as \"cytokine storm\", while inducing lymphopenia and a disrupted immune response. Obesity is associated with chronic low-grade inflammation and immune dysregulation, but the exact mechanisms through which it exacerbates COVID-19 infection are not fully clarified. The production of increased amounts of cytokines such as TNF-alpha, IL-1, IL-6 and MCP-1 lead to oxidative stress and defective function of innate and adaptive immunity, while the activation of NLRP3 inflammasome seems to play a crucial role in the pathogenesis of the infection. Endothelial dysfunction and arterial stiffness could favor the recently discovered infection of the endothelium by SARS-CoV-2, while alterations in cardiac structure and function and the pro-thrombotic microenvironment in obesity could provide a link for the increased cardiovascular events in these patients. The successful use of anti-inflammatory agents such as IL-1 and IL-6 blockers in similar hyper-inflammatory settings like that of rheumatoid arthritis has triggered the discussion of whether such agents could be administrated in selected patients with COVID-19 disease.","Am J Physiol Endocrinol Metab","Korakas, Emmanouil","Ikonomidis, Ignatios","Kousathana, Foteini","Balampanis, Konstantinos","Kountouri, Aikaterini","Raptis, Athanasios","Palaiodimou, Lina","Kokkinos, Alexander","Lambadiari, Vaia","32459524"],"abstract":["Recent reports have shown a strong association between obesity and the severity of COVID-19 infection, even in the absence of other co-morbidities. After infecting the host cells, SARS-CoV-2 may cause a hyper-inflammatory reaction through the excessive release of cytokines, a condition known as \"cytokine storm\", while inducing lymphopenia and a disrupted immune response. Obesity is associated with chronic low-grade inflammation and immune dysregulation, but the exact mechanisms through which it exacerbates COVID-19 infection are not fully clarified. The production of increased amounts of cytokines such as TNF-alpha, IL-1, IL-6 and MCP-1 lead to oxidative stress and defective function of innate and adaptive immunity, while the activation of NLRP3 inflammasome seems to play a crucial role in the pathogenesis of the infection. Endothelial dysfunction and arterial stiffness could favor the recently discovered infection of the endothelium by SARS-CoV-2, while alterations in cardiac structure and function and the pro-thrombotic microenvironment in obesity could provide a link for the increased cardiovascular events in these patients. The successful use of anti-inflammatory agents such as IL-1 and IL-6 blockers in similar hyper-inflammatory settings like that of rheumatoid arthritis has triggered the discussion of whether such agents could be administrated in selected patients with COVID-19 disease."],"journal":"Am J Physiol Endocrinol Metab","authors":["Korakas, Emmanouil","Ikonomidis, Ignatios","Kousathana, Foteini","Balampanis, Konstantinos","Kountouri, Aikaterini","Raptis, Athanasios","Palaiodimou, Lina","Kokkinos, Alexander","Lambadiari, Vaia"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32459524","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1152/ajpendo.00198.2020","keywords":["covid-19","obesity","arterial stiffness","cytokines","immune system"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667967699029852161,"score":246.03354},{"pmid":32423059,"title":"Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.","text":["Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.","As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great effort is being made to understand the disease pathogenesis and host factors that predispose to disease progression in an attempt to find a window of opportunity for intervention. In addition to the direct cytopathic effect of the virus, the host hyper-inflammatory response has emerged as a key factor in determining disease severity and mortality. Accumulating clinical observations raised hypotheses to explain why some patients develop more severe disease while others only manifest mild or no symptoms. So far, Covid-19 management remains mainly supportive. However, many researches are underway to clarify the role of antiviral and immunomodulating drugs in changing morbidity and mortality in patients who become severely ill. This review summarizes the current state of knowledge on the interaction between SARS-CoV-2 and the host immune system and discusses recent findings on proposed pharmacologic treatments.","Vaccines (Basel)","Lega, Sara","Naviglio, Samuele","Volpi, Stefano","Tommasini, Alberto","32423059"],"abstract":["As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great effort is being made to understand the disease pathogenesis and host factors that predispose to disease progression in an attempt to find a window of opportunity for intervention. In addition to the direct cytopathic effect of the virus, the host hyper-inflammatory response has emerged as a key factor in determining disease severity and mortality. Accumulating clinical observations raised hypotheses to explain why some patients develop more severe disease while others only manifest mild or no symptoms. So far, Covid-19 management remains mainly supportive. However, many researches are underway to clarify the role of antiviral and immunomodulating drugs in changing morbidity and mortality in patients who become severely ill. This review summarizes the current state of knowledge on the interaction between SARS-CoV-2 and the host immune system and discusses recent findings on proposed pharmacologic treatments."],"journal":"Vaccines (Basel)","authors":["Lega, Sara","Naviglio, Samuele","Volpi, Stefano","Tommasini, Alberto"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32423059","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3390/vaccines8020224","keywords":["covid-19","sars-cov-2","t cell repertoire","antiviral immunity","coronavirus","cytokine storm","immune response"],"topics":["Treatment"],"weight":1,"_version_":1667352728842534913,"score":226.75569},{"pmid":32502542,"pmcid":"PMC7266583","title":"The immune system and COVID-19: Friend or foe?","text":["The immune system and COVID-19: Friend or foe?","AIM: Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection caused by SARS-CoV-2, which has been became a global public health challenge. The pathogenesis of this virus is not yet clearly understood, but there is evidence of a hyper-inflammatory immune response in critically ill patients, which leads to acute respiratory distress syndrome (ARDS) and multi-organ failure. MATERIAL AND METHODS: A literature review was performed to identify relevant articles on COVID-19 published up to April 30, 2020. The search resulted in 361 total articles. After reviewing the titles and abstracts for inclusion, some irrelevant papers were excluded. Additional relevant articles were identified from a review of citations referenced. KEY FINDINGS: SARS-CoV-2, directly and indirectly, affects the immune system and avoids being eliminated in early stages. On the other hand, the secretion of inflammatory cytokines creates critical conditions that lead to multi-organ failure. SIGNIFICANCE: The immune system which is affected by the virus tries to respond via a cytokine storm and hyperinflammation, which itself leads to further multi-organ damage and even death.","Life Sci","Yazdanpanah, Fereshteh","Hamblin, Michael R","Rezaei, Nima","32502542"],"abstract":["AIM: Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection caused by SARS-CoV-2, which has been became a global public health challenge. The pathogenesis of this virus is not yet clearly understood, but there is evidence of a hyper-inflammatory immune response in critically ill patients, which leads to acute respiratory distress syndrome (ARDS) and multi-organ failure. MATERIAL AND METHODS: A literature review was performed to identify relevant articles on COVID-19 published up to April 30, 2020. The search resulted in 361 total articles. After reviewing the titles and abstracts for inclusion, some irrelevant papers were excluded. Additional relevant articles were identified from a review of citations referenced. KEY FINDINGS: SARS-CoV-2, directly and indirectly, affects the immune system and avoids being eliminated in early stages. On the other hand, the secretion of inflammatory cytokines creates critical conditions that lead to multi-organ failure. SIGNIFICANCE: The immune system which is affected by the virus tries to respond via a cytokine storm and hyperinflammation, which itself leads to further multi-organ damage and even death."],"journal":"Life Sci","authors":["Yazdanpanah, Fereshteh","Hamblin, Michael R","Rezaei, Nima"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502542","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.lfs.2020.117900","keywords":["acute respiratory distress syndrome","covid-19","cytokine storm","hyperinflammation","immune system"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668890966397812737,"score":220.78656},{"pmid":32437586,"title":"Understanding the COVID-19 coagulopathy spectrum.","text":["Understanding the COVID-19 coagulopathy spectrum.","The SARS-Cov-2 (COVID-19) pandemic has already claimed over 200,000 lives. Quite early on in this pandemic, it was recognised that the virus triggers the immune system leading to a cytokine storm in some severely ill patients [1]. This hyper-responsiveness has been suggested to be the predominant aetiology for clinical deterioration and mortality in patients with this infection [2]. More recently, there have been several reports of increased thrombotic events in these patients [3-6]. From a laboratory perspective, this hypercoagulability is reflected in the marked elevation of the fibrinolytic marker, D-dimer, in almost all hospitalised COVID-19 patients [7]. We must, therefore, ask ourselves what is the link between the extremes of the immune system, presenting as cytokine storm, and the extremes of coagulation, presenting as arterial and venous thromboembolism?","Anaesthesia","Thachil, J","Agarwal, S","32437586"],"abstract":["The SARS-Cov-2 (COVID-19) pandemic has already claimed over 200,000 lives. Quite early on in this pandemic, it was recognised that the virus triggers the immune system leading to a cytokine storm in some severely ill patients [1]. This hyper-responsiveness has been suggested to be the predominant aetiology for clinical deterioration and mortality in patients with this infection [2]. More recently, there have been several reports of increased thrombotic events in these patients [3-6]. From a laboratory perspective, this hypercoagulability is reflected in the marked elevation of the fibrinolytic marker, D-dimer, in almost all hospitalised COVID-19 patients [7]. We must, therefore, ask ourselves what is the link between the extremes of the immune system, presenting as cytokine storm, and the extremes of coagulation, presenting as arterial and venous thromboembolism?"],"journal":"Anaesthesia","authors":["Thachil, J","Agarwal, S"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437586","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/anae.15141","keywords":["covid-19","coagulation","thrombosis"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667521393636409344,"score":206.63303},{"pmid":32387470,"title":"COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?","text":["COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?","The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term \"hyperferritinemic syndrome\" and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic inflammatory reaction and \"hyperferritinemic syndromes\" are all characterized by high serum ferritin and a life-threatening hyper-inflammation sustained by a cytokines storm which eventually leads to multi-organ failure. In this review, we analyze the possible epidemiological and molecular mechanisms responsible for hyper-inflammation in patients with severe COVID-19 and we underline the similarities between this condition and \"hyperferritinemic syndromes\" which would allow considering this entity as the fifth member of the spectrum of inflammatory conditions.","Autoimmun Rev","Colafrancesco, Serena","Alessandri, Cristiano","Conti, Fabrizio","Priori, Roberta","32387470"],"abstract":["The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term \"hyperferritinemic syndrome\" and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic inflammatory reaction and \"hyperferritinemic syndromes\" are all characterized by high serum ferritin and a life-threatening hyper-inflammation sustained by a cytokines storm which eventually leads to multi-organ failure. In this review, we analyze the possible epidemiological and molecular mechanisms responsible for hyper-inflammation in patients with severe COVID-19 and we underline the similarities between this condition and \"hyperferritinemic syndromes\" which would allow considering this entity as the fifth member of the spectrum of inflammatory conditions."],"journal":"Autoimmun Rev","authors":["Colafrancesco, Serena","Alessandri, Cristiano","Conti, Fabrizio","Priori, Roberta"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387470","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.autrev.2020.102573","keywords":["covid-19","cytokine storm","ferritin","inflammation"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666428892708077568,"score":201.57788}]}